DarioHealth Corp expected to post a loss of 71  cents a share - Earnings Preview

DarioHealth

12/08/2022 12:11

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 15
(estimated). 
    * The New York City-based  company is expected to report  a
56.5% increase in revenue to $8.235 million from $5.26 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for DarioHealth Corp is
for a
loss of 71 cents per share. For the same quarter last year, the
company reported a loss of 99 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $18​, above​ its last closing price of $6.99. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.96       -0.96      -0.74     Beat    22.7
 Dec. 31 2022  -1.09       -1.06      -1.09     Missed  -3.2
 Sep. 30 2021  -0.91       -0.94      -1.18     Missed  -26.1​
 Jun. 30 2021  -0.87       -0.85      -0.99     Missed  -15.8
 ​​Mar.        -1.18       -1.04      -0.92     Beat    11.7
 31 2021                                                
 Dec. 31 2020  -0.77       -0.81      -1.06     Missed  -30.5​
 Sep. 30 2020  -0.68       -0.68      -0.71     Missed  -3.9
 Jun. 30 2020  -1.40       -1.40      -0.68     Beat    51.3
 This summary was machine generated August 12 at 11:11 GMT.  All
figures in US dollars  unless otherwise stated